Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 4Ovarian Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Neurofibrosarcoma 1Mesothelioma, Malignant 1Malignant mesenchymal tumor 1Ichthyosis, X-Linked 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma, Extraskeletal Myxoid 1

Interventions

Thiotepa 2Melphalan 2Doxorubicin 2thymoglobulin 1sodium thiosulfate 1omburtamab I-131 1fludarabine phosphate 1X-Rays 1Trabectedin 1Tacrolimus 1Stem Cell Transplantation 1Specimen Handling 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1Hyperthermic Intraperitoneal Chemotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cytoreduction Surgical Procedures 1Cyclosporins 1Cyclosporine 1Cisplatin 1Busulfan 1Bone Marrow Transplantation 1Antilymphocyte Serum 1Amifostine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Desmoplastic Small Round Cell Tumor × Trabectedin × Clear all
NCT01189253 2014-08-08

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
133 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡